Sinopharm Group Co(HK:1099)
HK$16.67-0.07 (-0.42%)
HK:1099
Sinopharm Group Co financials statements
HK$16.67
At close:-0.07 (-0.42%)
Want to see HK:1099 full AI Analyst Report?
Sinopharm Group Co (1099) Income Statement
11 Followers
Sinopharm Group Co Income Statement
Last quarter (Q2 2026), Sinopharm Group Co's total revenue was ¥278.90B, a decrease of 5.37% from the same quarter last year. In Q2, Sinopharm Group Co's net income was ¥3.36B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 575.17B | ¥ 584.51B | ¥ 596.57B | ¥ 552.15B | ¥ 521.05B | |
| ¥ 41.67B | ¥ 44.26B | ¥ 48.51B | ¥ 47.43B | ¥ 44.05B | |
| ¥ 25.63B | ¥ 28.07B | ¥ 28.30B | ¥ 26.83B | ¥ 24.34B | |
| Depreciation and Amortization | ¥ 4.29B | ¥ 4.74B | ¥ 4.43B | ¥ 4.17B | ¥ 3.92B |
| ¥ 21.52B | ¥ 22.56B | ¥ 26.90B | ¥ 26.25B | ¥ 24.68B | |
| ¥ 16.04B | ¥ 16.19B | ¥ 20.21B | ¥ 20.60B | ¥ 19.71B | |
| ¥ -1.24B | ¥ -2.19B | ¥ -697.06M | ¥ -2.04B | ¥ -2.71B | |
| ¥ 14.80B | ¥ 14.00B | ¥ 19.51B | ¥ 18.56B | ¥ 17.00B | |
| ¥ 7.16B | ¥ 7.05B | ¥ 9.05B | ¥ 8.53B | ¥ 7.76B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 2.29 | ¥ 2.26 | ¥ 2.90 | ¥ 2.73 | ¥ 2.49 |
| Diluted EPS | ¥ 2.29 | ¥ 2.26 | ¥ 2.90 | ¥ 2.73 | ¥ 2.49 |
| Weighted Average Shares Outstanding | 3.12B | 3.12B | 3.12B | 3.12B | 3.11B |
| Weighted Average Shares Outstanding (Diluted) | 3.12B | 3.12B | 3.12B | 3.12B | 3.11B |
Currency in CNY

